EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...

Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...

and are at increased risk of developing Alzheimer’s disease. Those with one copy are at increased risk too. Leqembi, which is ...

A single course of newly approved Alzheimer's drug donanemab-azbt, the second medicine available in Japan targeting proteins in the brains of sufferers of the debilitating disease, will cost 3.08 ...

Denali Therapeutics' innovative approach to neurological disorders and strong financial strategy position it as a leader in ...

Los Angeles Capital Management LLC bought a new stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the third ...

Venturi Wealth Management LLC raised its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 73.8% in the 3rd quarter, ...

GRAND JUNCTION, Colo. ( KREX) – A head-on collision affected traffic Friday night at North Avenue and 12th Street. Around ...

Pfizer stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and ...

When Labour took power in July it inherited an economy that had taken a beating but was starting to recover at speed. Not anymore.

Delhi Air Pollution: Delhi continued to battle a worsening pollution crisis, with its air quality plunging into the 'severe' category for a fourth consecutive day.